Furthermore, 7k modulated immune checkpoint signaling by downregulating PD-L1 expression in cancer cells and suppressing PD-1 expression in T cells, a dual immunomodulatory effect that expands its therapeutic relevance. This evidence concerns the gene PDCD1 and cancer.